OROS-METHYLPHENIDATE OR PLACEBO FOR ADULT SMOKERS WITH ATTENTION DEFICIT HYPERACTIVITY DISORDER: RACIAL/ETHNIC DIFFERENCES
Kaydedildi:
COVEY, L.S., ET AL., OROS-METHYLPHENIDATE OR PLACEBO FOR ADULT SMOKERS WITH ATTENTION DEFICIT HYPERACTIVITY DISORDER: RACIAL/ETHNIC DIFFERENCES. DRUG AND ALCOHOL DEPENDENCE, Vol. 110, no. 1-2 (2010), p. 156-159.
Ref.
171606
Yer:
SIIS R.854 Archivo
Palabras clave:
Desintoxicación, Drogodependencias, Etnia, Hiperactividad, Nicotina de sustitución, Patrones de consumo, Tabaco, Trastornos de atención, Tratamiento, EE.UU.
Desintoxicación, Drogodependencias, Etnia, Hiperactividad, Nicotina de sustitución, Patrones de consumo, Tabaco, Trastornos de atención, Tratamiento, EE.UU.
Benzer Materyaller: OROS-METHYLPHENIDATE OR PLACEBO FOR ADULT SMOKERS WITH ATTENTION DEFICIT HYPERACTIVITY DISORDER: RACIAL/ETHNIC DIFFERENCES
- A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF ADDERALL AND METHYLPHENIDATE IN THE TREATMENT OF ATTENTION-DEFICIT / HYPERACTIVITY DISORDER
- BUPROPION VERSUS METHYLPHENIDATE IN THE TREATMENT OF ATTENTION-DEFICIT HYPERACTIVITY DISORDER
- Anxiety and depressed mood decline following smoking abstinence in adult smokers with attention deficit hyperactivity disorder
- PREDICTION OF CLINICAL RESPONSE TO METHYLPHENIDATE IN CHILDREN WITH ATTENTION-DEFICIT HYPERACTIVITY DISORDER
- Methylphenidate for attention deficit hyperactivity disorder and drug relapse in criminal offenders with substance dependence: a 24-week randomized placebo-controlled trial
- METHYLPHENIDATE TREATMENT OF ATTENTION-DEFICIT HYPERACTIVITY DISORDER IN BOYS WITH TOURETTE'S SYNDROME